Mifepristone blocks progesterone, the hormone required to maintain pregnancy. Within 24–48 hours, Misoprostol is administered to induce uterine contractions and expel pregnancy tissue.
Recommended for:
Women with confirmed intrauterine pregnancy up to 63 days
Those opting for medical abortion over surgical procedures
Under physician supervision or regulated telemedical care
Safe use in accordance with national clinical protocols
For medical termination of confirmed intrauterine pregnancy up to 63 days of gestation.
One tablet of Mifepristone is taken orally, followed by four tablets of Misoprostol 24–48 hours later, either sublingually, vaginally, or buccally as advised by the physician. Follow-up is necessary to confirm the completion of abortion.
Contraindicated in ectopic pregnancy, bleeding disorders, adrenal insufficiency, severe anaemia, or hypersensitivity to ingredients. Possible side effects: heavy bleeding, abdominal cramping, nausea, fever, weakness, dizziness.
